{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:58:35Z","timestamp":1775289515925,"version":"3.50.1"},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2019,3,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Background: Curcumin is a well-known pharmacophore and some of its derivatives are shown to target xanthine oxidase (XO) to alleviate disorders caused by the excess production of uric acid. &lt;\/p&gt;&lt;p&gt; Objective: Curcumin based derivatives were designed, synthesized and evaluated for their antioxidant and xanthine oxidase inhibitory potential. &lt;\/p&gt;&lt;p&gt; Method: In this report, we designed and synthesized two series of curcumin derivatives modified by inserting pyrazole and pyrimidine ring to central keto group. The synthesized compounds were evaluated for their antioxidant and xanthine oxidase inhibitory potential. &lt;\/p&gt;&lt;p&gt; Results: Results showed that pyrazole analogues of curcumin produced excellent XO inhibitory potency with the IC50 values varying from 06.255 &amp;#181;M to 10.503 &amp;#181;M. Among pyrimidine derivatives compound CU3a1 having ortho nitro substitution exhibited more potent xanthine oxidase inhibitory activity than any other curcumin derivative of this series. &lt;\/p&gt;&lt;p&gt; Conclusion: Curcumin derivatives CU5b1, CU5b2, CU5b3, and CU3a1 showed a potent inhibitory activity against xanthine oxidase along with good antioxidant potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389450120666181122100511","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T06:33:11Z","timestamp":1543473191000},"page":"593-603","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["<i>In Silico<\/i>\n                    Design and Synthesis of Targeted Curcumin Derivatives as Xanthine Oxidase Inhibitors"],"prefix":"10.2174","volume":"20","author":[{"given":"Neelam","family":"Malik","sequence":"first","affiliation":[{"name":"Laboratory for Preservation Technology and Enzyme Inhibition Studies, Department of Pharmaceutical Sciences, M.D.University, Rohtak, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Dhiman","sequence":"additional","affiliation":[{"name":"Laboratory for Preservation Technology and Enzyme Inhibition Studies, Department of Pharmaceutical Sciences, M.D.University, Rohtak, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Khatkar","sequence":"additional","affiliation":[{"name":"Laboratory for Preservation Technology and Enzyme Inhibition Studies, Department of Pharmaceutical Sciences, M.D.University, Rohtak, Haryana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/3-540-62888-6_3","author":"Rom\u00e3o M.J.","year":"1998","unstructured":"Rom\u00e3o MJ, Huber R.","journal-title":"Structure and function of the xanthine-oxidase family of molybdenum enzymes InMetal Sites in Proteins and Models Redox Centres"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cbpa.2006.01.034","volume":"10","author":"Brondino C.D.","year":"2006","unstructured":"Brondino CD, Rom\u00e3o MJ, Moura I, Moura JJ. Molybdenum and tungsten enzymes: the xanthine oxidase family.","journal-title":"Curr Opin Chem Biol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1113\/jphysiol.2003.055913","volume":"555","author":"Berry C.E.","year":"2004","unstructured":"Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.","journal-title":"J Physiol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","volume":"33","author":"Harrison R.","year":"2002","unstructured":"Harrison R. Structure and function of xanthine oxidoreductase: where are we now?","journal-title":"Free Radic Biol Med"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.12659\/MSM.899852","volume":"22","author":"Chen C.","year":"2016","unstructured":"Chen C, L\u00fc JM, Yao Q. Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview.","journal-title":"Med Sci Monit"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2015.08.087","volume":"213","author":"Gliozzi M.","year":"2016","unstructured":"Gliozzi M, Malara N, Muscoli S, Mollace V. The treatment of hyperuricemia.","journal-title":"Int J Cardiol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00775-014-1210-x","volume":"20","author":"Nishino T.","year":"2015","unstructured":"Nishino T, Okamoto K. Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.","journal-title":"J Biol Inorg Chem"},{"key":"ref=8","first-page":"811","volume":"10","author":"Haidari F.","year":"2011","unstructured":"Haidari F, Keshavarz SA, Shahi MM, Mahboob SA, Rashidi MR. Effects of parsley (Petroselinum crispum) and its flavonol constituents, kaempferol and quercetin, on serum uric acid levels, biomarkers of oxidative stress and liver xanthine oxidoreductase aactivityinoxonate-induced hyperuricemic rats.","journal-title":"Iran J Pharm Res"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.7326\/0003-4819-62-4-639","volume":"62","author":"Klinenberg J.R.","year":"1965","unstructured":"Klinenberg JR, Goldfinger SE, Seegmiller JE. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout.","journal-title":"Ann Intern Med"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","volume":"58","author":"Pacher P.","year":"2006","unstructured":"Pacher P, Nivorozhkin A, Szab\u00f3 C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.","journal-title":"Pharmacol Rev"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.40.3.245","volume":"40","author":"McInnes G.T.","year":"1981","unstructured":"McInnes GT, Lawson DH, Jick H. Acute adverse reactions attributed to allopurinol in hospitalised patients.","journal-title":"Ann Rheum Dis"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.lfs.2004.10.031","volume":"76","author":"Takano Y.","year":"2005","unstructured":"Takano Y, Hase-Aoki K, Horiuchi H. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase.","journal-title":"Life Sci"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","volume":"52","author":"Becker M.A.","year":"2005","unstructured":"Becker MA, Schumacher HR, Wortmann RL. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: A twenty\u2010eight\u2013day, multicenter, phase II, randomized, double\u2010blind, placebo\u2010controlled, dose\u2010response clinical trial examining safety and efficacy in patients with gout.","journal-title":"Arthritis Rheum"},{"key":"ref=14","first-page":"824","volume":"12","author":"Iwanaga T.","year":"2005","unstructured":"Iwanaga T, Kobayashi D, Hirayama M, Maeda T, Tamai I. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.","journal-title":"Drug Metab Dispos"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-291X(87)91112-0","volume":"148","author":"Das D.K.","year":"1987","unstructured":"Das DK, Engelman RM, Clement R. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage. \u200e.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/annrheumdis-2017-eular.5308","author":"Hall J.","year":"2017","unstructured":"Hall J, Gillen M, Yang X. THU0432 Pharmacokinetics, pharmacodynamics, and tolerability of concomitant multiple dose administration of verinurad (RDEA3170) and allopurinol in adult male subjects with gout.","journal-title":"Ann Rheum Dis"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1021\/ja1077574","volume":"132","author":"Okamoto K.","year":"2010","unstructured":"Okamoto K, Kawaguchi Y, Eger BT, Pai EF, Nishino T. Crystal structures of urate bound form of xanthine oxidoreductase: substrate orientation and structure of the key reaction intermediate. \u200e.","journal-title":"J Am Chem Soc"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/15257770802146577","volume":"27","author":"Okamoto K.","year":"2008","unstructured":"Okamoto K, Eger BT, Nishino T, Pai EF, Nishino T. Mechanism of inhibition of xanthine oxidoreductase by allopurinol: crystal structure of reduced bovine milk xanthine oxidoreductase bound with oxipurinol.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/wound.2016.0724","volume":"7","author":"Fernandez M.L.","year":"2018","unstructured":"Fernandez ML, Stupar D, Croll T, Leavesley D, Upton Z. Xanthine oxidoreductase: a novel therapeutic target for the treatment of chronic wounds?","journal-title":"Adv Wound Care"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ph11020051","volume":"11","author":"Jordan A.","year":"2018","unstructured":"Jordan A, Gresser U. Side effects and interactions of the xanthine oxidase inhibitor febuxostat.","journal-title":"Pharmaceuticals"},{"key":"ref=21","first-page":"31","author":"Bordoloi D.","year":"2018","unstructured":"Bordoloi D, Kunnumakkara AB.","journal-title":"The potential of curcumin: A multitargeting agent in cancer cell chemosensitization InRole of nutraceuticals in cancer chemosensitization"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","volume":"32","author":"Prasad S.","year":"2014","unstructured":"Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: from bedside to bench and back.","journal-title":"Biotechnol Adv"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.intimp.2014.03.009","volume":"20","author":"Kant V.","year":"2014","unstructured":"Kant V, Gopal A, Pathak NN. Antioxidant and anti-inflammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats.","journal-title":"Int Immunopharmacol"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.biomaterials.2015.02.116","volume":"53","author":"Wang J.","year":"2015","unstructured":"Wang J, Wang H, Zhu R. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1\u03b2 transgenic mice subjected to the lipopolysaccharide-induced sepsis.","journal-title":"Biomat"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12931-015-0199-1","volume":"16","author":"Zhang Y.","year":"2015","unstructured":"Zhang Y, Liang D, Dong L. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.","journal-title":"Respir Res"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.intimp.2016.05.007","volume":"36","author":"Cianciulli A.","year":"2016","unstructured":"Cianciulli A, Calvello R, Porro C. PI3k\/Aktsignalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia.","journal-title":"Int Immunopharmacol"},{"key":"ref=27","author":"Edwards RL","year":"2017","unstructured":"Edwards RL, Luis PB, Varuzza PV. The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites.","journal-title":"J Biol Chem"},{"key":"ref=28","first-page":"105","author":"Menon V.P.","year":"2007","unstructured":"Menon VP, Sudheer AR. The molecular targets and therapeutic uses of curcumin in health and disease","journal-title":"Antioxidant and anti-inflammatory properties of curcumin"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bmc.2016.10.022","volume":"25","author":"Ao G.Z.","year":"2017","unstructured":"Ao GZ, Zhou MZ, Li YY. Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.","journal-title":"Bioorg Med Chem"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2174\/1389200218666170316092531","volume":"18","author":"Malik N.","year":"2017","unstructured":"Malik N, Dhiman P, Khatkar A. design and admet studies of natural compounds as inhibitors of xanthine oxidase (xo) enzyme.","journal-title":"Curr Drug Metab"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1007\/s11164-015-1922-8","volume":"41","author":"Dhiman P.","year":"2015","unstructured":"Dhiman P, Malik N, Verma PK, Khatkar A. Synthesis and biological evaluation of thiazolo and imidazo N-(4-nitrophenyl)-7-methyl-5-aryl-pyrimidine-6 carboxamide derivatives.","journal-title":"Res Chem Intermed"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/0974-8490.65509","volume":"2","author":"Patel A.","year":"2010","unstructured":"Patel A, Patel NM. Determination of polyphenols and free radical scavenging activity of Tephrosia purpurea linn leaves (Leguminosae).","journal-title":"Pharmacogn Rev"},{"key":"ref=33","first-page":"341","volume":"22","author":"Chou K.C.","year":"1979","unstructured":"Chou KC, Jiang SP, Liu WM, Fee CH. Graph theory of enzyme kinetics: 1. Steady-state reaction system.","journal-title":"Sci Sin"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1042\/bj1870829","volume":"187","author":"Chou K.C.","year":"1980","unstructured":"Chou KC, Forsen S. Graphical rules for enzyme-catalyzed rate laws.","journal-title":"Biochem J"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1042\/bj2220169","volume":"222","author":"Zhou G.P.","year":"1984","unstructured":"Zhou GP, Deng MH. An extension of Chou\u2019s graphic rules for deriving enzyme kinetic equations to systems involving parallel reaction pathways.","journal-title":"Biochem J"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"12074","DOI":"10.1016\/S0021-9258(18)80175-2","volume":"264","author":"Chou K.C.","year":"1989","unstructured":"Chou KC. Graphic rules in steady and non-steady enzyme kinetics.","journal-title":"J Biol Chem"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/S0021-9258(18)53227-0","volume":"268","author":"Althaus I.W.","year":"1993","unstructured":"Althaus IW, Chou JJ, Gonzales AJ. Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E.","journal-title":"J Biol Chem"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-4622(90)80056-D","volume":"35","author":"Chou K.C.","year":"1990","unstructured":"Chou KC. Review: Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady state systems.","journal-title":"Biophys Chem"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1016\/S0021-9258(18)82414-0","volume":"268","author":"Althaus I.W.","year":"1993","unstructured":"Althaus IW, Gonzales AJ, Chou JJ. The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase.","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/138920010791514261","volume":"11","author":"Chou K.C.","year":"2010","unstructured":"Chou KC. Graphic rule for drug metabolism systems.","journal-title":"Curr Drug Metab"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtbi.2011.06.006","volume":"284","author":"Zhou G.P.","year":"2011","unstructured":"Zhou GP. The disposition of the LZCC protein residues in wenxiang diagram provides new insights into the protein-protein interaction mechanism.","journal-title":"J Theor Biol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.1021\/bi00077a008","volume":"32","author":"Althaus I.W.","year":"1993","unstructured":"Althaus IW, Chou JJ, Gonzales AJ. Kinetic studies with the nonnucleoside HIV-1 reverse transcriptase inhibitor U-88204E.","journal-title":"Biochem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2174\/0929867043364667","volume":"11","author":"Chou K.C.","year":"2004","unstructured":"Chou KC. Review: Structural bioinformatics and its impact to biomedical science.","journal-title":"Curr Med Chem"},{"key":"ref=44","first-page":"420","volume":"259","author":"Chou K.C.","year":"1999","unstructured":"Chou KC, Watenpaugh KD, Heinrikson RL. A Model of the complex between cyclindependent kinase 5 (Cdk5) and the activation domain of neuronal Cdk5 activator.","journal-title":"BBRC"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/prot.10173","volume":"48","author":"Zhang J.","year":"2002","unstructured":"Zhang J, Luan CH, Johnson GVW. Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling Proteins.","journal-title":"Struct Funct Genet"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-5793(97)01246-5","volume":"419","author":"Chou K.C.","year":"1997","unstructured":"Chou KC, Jones D, Heinrikson RL. Prediction of the tertiary structure and substrate binding site of caspase-8.","journal-title":"FEBS Lett"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-5793(00)01333-8","volume":"470","author":"Chou K.C.","year":"2000","unstructured":"Chou KC, Tomasselli AG, Heinrikson RL. Prediction of the tertiary structure of a caspase-9\/inhibitor complex.","journal-title":"FEBS Lett"},{"key":"ref=48","first-page":"148","volume":"308","author":"Chou K.C.","year":"2003","unstructured":"Chou KC, Wei DQ, Zhong WZ. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (Erratum: ibid. 2003, Vol.310, 675).","journal-title":"BBRC"},{"key":"ref=49","first-page":"1243","volume":"377","author":"Huang R.B.","year":"2008","unstructured":"Huang RB, Du QS, Wang CH. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.","journal-title":"BBRC"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/pr049849v","volume":"3","author":"Chou K.C.","year":"2004","unstructured":"Chou KC. Molecular therapeutic target for type-2 diabetes.","journal-title":"J Proteome Res"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.1073\/pnas.0902548106","volume":"106","author":"Pielak R.M.","year":"2009","unstructured":"Pielak RM, Jason R, Schnell JR, Chou JJ. Mechanism of drug inhibition and drug resistance of influenza A M2 channel.","journal-title":"Proceedings of National Academy of Science USA"},{"key":"ref=52","first-page":"447","volume":"20","author":"Chou K.C.","year":"1977","unstructured":"Chou KC, Chen NY. The biological functions of low-frequency phonons.","journal-title":"Sci Sin"},{"key":"ref=53","first-page":"608","volume":"390","author":"Wang J.F.","year":"2009","unstructured":"Wang JF, Chou KC. Insight into the molecular switch mechanism of human Rab5a from molecular dynamics simulations.","journal-title":"BBRC"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0968-0004(89)90026-1","volume":"14","author":"Chou K.C.","year":"1989","unstructured":"Chou KC. Low-frequency resonance and cooperativity of hemoglobin.","journal-title":"Trends Biochem Sci"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/protein\/gzq040","volume":"23","author":"Wang J.F.","year":"2010","unstructured":"Wang JF, Chou KC. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.","journal-title":"PEDS"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/bip.360271109","volume":"27","author":"Chou K.C.","year":"1988","unstructured":"Chou KC, Mao B. Collective motion in DNA and its role in drug intercalation.","journal-title":"Biopolymers"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/bip.360340114","volume":"34","author":"Chou K.C.","year":"1994","unstructured":"Chou KC, Zhang CT, Maggiora GM. Solitary wave dynamics as a mechanism for explaining the internal motion during microtubule growth.","journal-title":"Biopolymers"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0301-4622(88)85002-6","volume":"30","author":"Chou K.C.","year":"1988","unstructured":"Chou KC. Review: Low-frequency collective motion in biomacromolecules and its biological functions.","journal-title":"Biophys Chem"},{"key":"ref=59","first-page":"623149","volume":"2014","author":"Chen W.","year":"2014","unstructured":"Chen W, Feng PM, Lin H. iSS-PseDNC: identifying splicing sites using pseudo dinucleotide composition.","journal-title":"BMRI"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ab.2013.05.024","volume":"442","author":"Feng P.M.","year":"2013","unstructured":"Feng PM, Chen W, Lin H, Chou KC. iHSP-PseRAAAC: Identifying the heat shock protein families using pseudo reduced amino acid alphabet composition.","journal-title":"Anal Biochem"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"16895","DOI":"10.18632\/oncotarget.7815","volume":"7","author":"Chen W.","year":"2016","unstructured":"Chen W, Ding H, Feng P, Lin H. iACP: a sequence-based tool for identifying anticancer peptides.","journal-title":"Oncotarget"},{"key":"ref=62","first-page":"1722","volume":"13","author":"Cheng X.","year":"2017","unstructured":"Cheng X, Xiao X, Chou KC. pLoc-mPlant: predict subcellular localization of multi-location plant proteins incorporating the optimal GO information into general PseAAC.","journal-title":"Mol Bio Sys"},{"key":"ref=63","first-page":"315","volume":"628","author":"Cheng X","year":"2017","unstructured":"Cheng X, Xiao X, Chou KC. pLoc-mVirus: predict subcellular localization of multi-location virus proteins incorporating the optimal GO information into general PseAAC Gene (Erratum: ibid,2018, Vol.644, 156-156)"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1093\/bioinformatics\/btx476","volume":"33","author":"Cheng X.","year":"2017","unstructured":"Cheng X, Zhao SG, Lin WZ, Xiao X, Chou KC. pLoc-mAnimal: predict subcellular localization of animal proteins with both single and multiple sites.","journal-title":"Bioinformatics"},{"key":"ref=65","first-page":"331","volume":"9","author":"Xiao X.","year":"2017","unstructured":"Xiao X, Cheng X, Su S, Nao Q, Chou KC. pLoc-mGpos: Incorporate key gene ontology information into general PseAAC for predicting subcellular localization of Gram-positive bacterial proteins.","journal-title":"Nat Sci"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygeno.2017.08.005","volume":"110","author":"Cheng X.","year":"2018","unstructured":"Cheng X, Xiao X. pLoc-mEuk: Predict subcellular localization of multi-label eukaryotic proteins by extracting the key GO information into general PseAAC.","journal-title":"Genomics"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygeno.2017.10.002","volume":"110","author":"Cheng X.","year":"2018","unstructured":"Cheng X, Xiao X, Chou KC. pLoc-mGneg: Predict subcellular localization of Gram-negative bacterial proteins by deep gene ontology learning general PseAAC.","journal-title":"Genomics"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/bioinformatics\/btx711","volume":"34","author":"Cheng X.","year":"2018","unstructured":"Cheng X, Xiao X, Chou KC. pLoc-mHum: predict subcellular localization of multi-location human proteins general PseAAC to winnow out the crucial GO information.","journal-title":"Bioinformatics"},{"key":"ref=69","author":"Cheng X.","year":"2018","unstructured":"Cheng X, Lin WZ, Xiao X. pLoc_bal-mAnimal: predict subcellular localization of animal proteins by balancing training dataset and PseAAC.","journal-title":"Bioinformatics"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/1573406411666141229162834","volume":"11","author":"Chou K.C.","year":"2015","unstructured":"Chou KC. Impacts of bioinformatics to medicinal chemistry.","journal-title":"Med Chem"},{"key":"ref=71","first-page":"2337","volume":"17","author":"Chou K.C.","year":"2017","unstructured":"Chou KC. An unprecedented revolution in medicinal chemistry driven by the progress of biological science.","journal-title":"Curr Top Med Chem"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/167662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:10:17Z","timestamp":1775286617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/167662\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,3,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450120666181122100511","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}